Nat Rothman

Methods for etiologic and early marker investigations in the PLCO trial

Richard B. Hayes, Alice J. Sigurdson, Lee E. Moore et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2005 · 145 citations

Medicine, Internal Medicine, Clinical Pharmacology +5

Pharmacokinetic Variability and Modern Epidemiology—The Example of Dichlorodiphenyltrichloroethane, Body Mass Index, and Birth Cohort

Mary S. Wolff, Henry A. Anderson, Julie A. Britton et al. · Cancer Epidemiology Biomarkers & Prevention · 2007 · 121 citations

Pharmacy, Pharmacokinetics, Toxicology +14

Organochlorines in Carpet Dust and Non-Hodgkin Lymphoma

Joanne S. Colt, Richard K. Severson, Jay H. Lubin et al. · Epidemiology · 2005 · 117 citations

Pharmacy, Environmental Sciences, Toxicology +15

Dietary Intake of Heterocyclic Amines and Benzo(<i>a</i>)Pyrene: Associations with Pancreatic Cancer

Kristin E. Anderson, Fred F. Kadlubar, Martin Kulldorff et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 103 citations · Full text

Public Health, Nutritional Sciences, Toxicology +16

Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.

Anneclaire J. De Roos, Nat Rothman, Peter D. Inskip et al. · PubMed · 2003 · 93 citations

Life Sciences, Genetics, Oncology +10